Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. The company offers Chinese patent medicines, chemical medicines, and heal...
Pre-market hot trades in US stocks: Planet Green fell 3.89% in pre-market; IREN rose 3.82% in pre-market
REG - GSK PLC - Hansoh positive 2nd Phase III results for Riz-Rez
The Shangai Composite Index Closes 0.96% Lower
KMYY released its performance for the first three quarters, with a net profit attributable to the parent company of 13.08 million yuan, a year-on-year increase of 160.84%
KMYY released its semi-annual performance, with a net profit attributable to the parent company of 16.9 million yuan, a year-on-year increase of 7.24%
KMYY: Plans to sign a settlement agreement with related party Guangzhou Pharmaceutical Group to resolve historical debt issues for 43.5 million yuan